Please support and help spread awareness of MAPS (Multidisciplinary Association for Psychedelic Studies) research. MDMA studies are foot in the door for a big change in psychedelic drug policies worldwide. Not to mention its an incredible psycho-therapeutic tool on its own, capable of helping millions.
In a recently completed study, 83% of subjects receiving MDMA-assisted psychotherapy no longer qualified for PTSD, and everyone who received a placebo and then went on to receive MDMA-assisted psychotherapy experienced significant and lasting improvements. These results were published in the Journal of Psychopharmacology. These subjects had suffered from PTSD for an average of 19 years.